SALION GMBH has a total of 15 patent applications. It increased the IP activity by 300.0%. Its first patent ever was published in 2013. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets measurement are GUANGZHOU YUANQI HEALTH TECH CO LTD, FOOD INSPECTION AND QUARANTINE CT OF SHENZHEN ENTRY EXIT INSPECTION AND QUARANTINE BUREAU and VNII BIOLOG METODOV ZASHCHITY.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | United States | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Australia | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | Japan | 1 | |
#8 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Measurement |
# | Technology | |
---|---|---|
#1 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Abendroth Dietmar | 14 |
#2 | Marzinzig Michael | 14 |
#3 | Stangl Manfred J | 9 |
#4 | Stangl Manfred | 5 |
#5 | Dietmar Abendroth | 1 |
#6 | Manfred J Stangl | 1 |
#7 | Michael Marzinzig | 1 |
Publication | Filing date | Title |
---|---|---|
EP3413050A1 | In vitro method for the determination of neurodegenerative diseases | |
EP2799878A1 | In vitro method for the early detection of a potential inflammation, in particular associated with rejection of a transplant using kynurenine as a marker. |